South & Central America Radioactive Tracer Market Forecast to 2030
South & Central America Radioactive Tracer Market Forecast to 2030 – Regional Analysis – by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others), and End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Use of Radioactive Tracer in Cancer Diagnosis fuel the South & Central America Radioactive Tracer Market
Oncology is a significantly developing field in the healthcare sector, as cancer cases are increasing worldwide. According to Institute for Health Metrics and Evaluation (IHME), cancer is the second major cause of death after cardiovascular disorders. The use of advanced materials and drugs in the diagnosis and treatment of cancer has surged with prominent developments in oncology. Radioactive tracer-based imaging is one of the advanced diagnostic methods used to accurately diagnose cancer types, such as prostate cancer, gynecological cancer, and blood-borne cancer. Once injected into the body, these radioactive tracers attach to the cancer-specific sites, accurately diagnosing the cancer type. Tracer also helps determine the cancer development stage, enabling effective treatment and faster recovery in most cases. PET and SPECT are among the nuclear imaging techniques that use gamma emitters for detecting tumors. As the tumor grows, its uptake of the PET and SPECT conjugate increases over time, which improves contrast due to the presence of nuclear imaging agents. This further leads to blood clearance due to which clear diagnostic images can be generated. The most commonly used radioactive tracer for detecting cancer is F-18 fluorodeoxyglucose (18F-FDG), a compound similar to glucose or sugar. Cancer cells are highly active and need more energy, i.e., extra glucose, than normal cells. Imaging devices such as PET or SPECT detect this energy released by FDG to create an image showing the location of a radioactive tracer in the body. This helps determine the location of cancerous cells in the patient’s body so that the treatment can be tailored according to the type and stage of cancer. Thus, the increasing use of radioactive tracer in cancer diagnostics is anticipated to drive market expansion during the estimated timeframe.
South & Central America Radioactive Tracer Market Overview
The South & Central America radioactive tracer market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in the region is expected to grow due to the increasing number of cancer cases, growing government initiatives, and rising research and development for radioactive tracer.
South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Radioactive Tracer Market Segmentation
The South & Central America radioactive tracer market is segmented based on tracer type, test type, end user, application, and country. Based on tracer type, the South & Central America radioactive tracer market is segmented into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held the largest market share in 2022.
Based on test type, the South & Central America radioactive tracer market is segmented into PET, SPECT, and others. The PET segment held the largest market share in 2022.
Based on end user, the South & Central America radioactive tracer market is segmented into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held the largest market share in 2022.
Based on application, the South & Central America radioactive tracer market is segmented into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held the largest market share in 2022.
Based on country, the South & Central America radioactive tracer market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America dominated the South & Central America radioactive tracer market share in 2022.
Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, Novartis AG, Curium, and IBA Radiopharma Solutions are some of the leading players operating in the South & Central America radioactive tracer market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Publishing status: | |
| Geographical coverage: | |
| Year of Publication: |
According to the research team’ research,, the South & Central America radioactive tracer market was valued at US$ 476.96 million in 2022 and is expected to reach US$ 1,634.33 million by 2030, registering a CAGR of 16.6% from 2022 to 2030. Rising prevalence of chronic diseases and increasing use of nuclear imaging techniques are the critical factors attributed to the South & Central America radioactive tracer market expansion.
Increasing aging population, changing social behavior, rising adoption of a sedentary lifestyle, and accelerating urbanization are the key factors boosting the prevalence of obesity and other chronic diseases such as diabetes. Further, studies have long established that genes can cause chronic conditions such as cardiovascular disease (CVD), diabetes, obesity, Alzheimer’s disease (AD), and depression. CVDs, such as atherosclerosis, angina pectoris, and acute myocardial infarction, caused due to hectic lifestyles have become significant causes of mortality worldwide. As per the data provided by the WHO, CVDs are the predominant cause of death worldwide, recording estimated 17.9 million deaths each year. Diabetes is a life-threatening chronic disease with no functional cure. Diabetes of all types can lead to various complications in different body parts and increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are among the major complications associated with diabetes. The disease prevalence will likely increase by nearly 35% during the forecast period. Thus, an effective examination is a must for properly treating chronic diseases; hence, nuclear substances are used for diagnosis and examination purposes. These nuclear substances are used in diagnostic tests such as positron emission tomography (PET) and single-photon emission computerized tomography (SPECT) to diagnose chronic diseases such as neurological, cardiovascular, chronic lung, and chronic kidney diseases. the availability of several radiotracer across the globe makes it selection easy depending on the type of disease and its prognosis. Thus, the increasing incidences of chronic diseases are surging the demand for radioactive tracer, positively favoring market expansion.
On the contrary, short shelf-life of radioactive tracer hurdles the growth of South & Central America radioactive tracer market.
Based on tracer type, the South & Central America radioactive tracer market is categorized into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held 59.9% market share in 2022, amassing US$ 285.57 million. It is projected to garner US$ 919.64 million by 2030 to expand at 15.7% CAGR during 2022–2030.
Based on test type, the South & Central America radioactive tracer market is categorized into PET, SPECT, and others. The PET segment held 45.6% share of South & Central America radioactive tracer market in 2022, amassing US$ 217.59 million. It is projected to garner US$ 765.15 million by 2030 to expand at 17.0% CAGR during 2022–2030.
Based on end user, the South & Central America radioactive tracer market is categorized into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held 70.2% share of South & Central America radioactive tracer market in 2022, amassing US$ 334.75 million. It is projected to garner US$ 1,148.35 million by 2030 to expand at 16.7% CAGR during 2022–2030.
Based on application, the South & Central America radioactive tracer market is categorized into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held 61.1% share of South & Central America radioactive tracer market in 2022, amassing US$ 291.52 million. It is projected to garner US$ 971.53 million by 2030 to expand at 16.2% CAGR during 2022–2030.
Based on country, the South & Central America radioactive tracer market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that the Rest of South & Central America captured 38.0% share of South & Central America radioactive tracer market in 2022. It was assessed at US$ 181.39 million in 2022 and is likely to hit US$ 605.84 million by 2030, exhibiting a CAGR of 16.3% during 2022–2030.
Key players operating in the South & Central America radioactive tracer market are Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, Novartis AG, Curium, General Electric Co, and IBA Radiopharma Solutions, among others.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America radioactive tracer market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America radioactive tracer market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America radioactive tracer market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Radioactive Tracer Market – Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Rising Prevalence of Chronic Diseases
4.1.2 Increasing Use of Nuclear Imaging Techniques
4.2 Market Restraints
4.2.1 Short Shelf-Life of Radioactive Tracer
4.2.2 Availability of Substitutes to Nuclear Diagnostic Imaging Procedures
4.3 Market Opportunities
4.3.1 Presence of Emerging Economies and Growing Population
4.3.2 Development of Personalized Radiopharmaceuticals for Targeted Therapies
4.4 Future Trends
4.4.1 Use of Radioactive Tracer in Cancer Diagnosis
4.5 Impact Analysis:
5. Radioactive Tracer Market – South & Central America Market Analysis
5.1 Radioactive Tracer Market Revenue (US$ Mn), 2022 – 2030
6. South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 – by Tracer Types
6.1 Overview
6.2 Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
6.3 Technetium 99m and TC-97m
6.3.1 Overview
6.3.2 Technetium 99m and TC-97m: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Iodine 131
6.4.1 Overview
6.4.2 Iodine 131: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Iron 59
6.5.1 Overview
6.5.2 Iron 59: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Lutetium- 171
6.6.1 Overview
6.6.2 Lutetium- 171: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.7 RB82 and ammonia N-13
6.7.1 Overview
6.7.2 RB82 and ammonia N-13: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.8 Scandium 46
6.8.1 Overview
6.8.2 Scandium 46: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.9 Seaborgium-269
6.9.1 Overview
6.9.2 Seaborgium-269: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.10 Hassium -269
6.10.1 Overview
6.10.2 Hassium -269: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.11 Gallium Citrate GA 67
6.11.1 Overview
6.11.2 Gallium Citrate GA 67: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.12 PSMA GA68
6.12.1 Overview
6.12.2 PSMA GA68: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.13 FDDNP (F-18) and FDOPA (f-18)
6.13.1 Overview
6.13.2 FDDNP (F-18) and FDOPA (f-18): Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.14 Phosphorus 32 and Chromium -51
6.14.1 Overview
6.14.2 Phosphorus 32 and Chromium -51: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.15 Thallium-201
6.15.1 Overview
6.15.2 Thallium-201: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.16 F-18 FDG
6.16.1 Overview
6.16.2 F-18 FDG: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.17 F-18 FAPI
6.17.1 Overview
6.17.2 F-18 FAPI: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.18 GA 68 FAPI
6.18.1 Overview
6.18.2 GA 68 FAPI: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.19 F-18 PSMA
6.19.1 Overview
6.19.2 F-18 PSMA: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.20 DOTATOC/DOTANOC/DOTATATE Ga 68
6.20.1 Overview
6.20.2 DOTATOC/DOTANOC/DOTATATE Ga 68: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.21 Others
6.21.1 Overview
6.21.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 – by Test Type
7.1 Overview
7.2 Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 PET
7.3.1 Overview
7.3.2 PET: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
7.4 SPECT
7.4.1 Overview
7.4.2 SPECT: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 – by Application.
8.1 Overview
8.2 Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Oncology
8.3.1 Overview
8.3.2 Oncology: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Pulmonary
8.4.1 Overview
8.4.2 Pulmonary: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Neurology
8.5.1 Overview
8.5.2 Neurology: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Cardiology
8.6.1 Overview
8.6.2 Cardiology: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Centers
9.4.1 Overview
9.4.2 Diagnostic Centers: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Radioactive Tracer Market – Country Analysis
10.1 South & Central America Radioactive Tracer Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.2 South & Central America Radioactive Tracer Market by Country
10.1.2.1 Brazil
10.1.2.1.1 Overview
10.1.2.1.2 Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.1.3 Brazil Radioactive Tracer Market, by Tracer Types
10.1.2.1.4 Brazil Radioactive Tracer Market, by Test Type
10.1.2.1.5 Brazil Radioactive Tracer Market, by Application
10.1.2.1.6 Brazil Radioactive Tracer Market, by End-User
10.1.2.2 Argentina
10.1.2.2.1 Overview
10.1.2.2.2 Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.3 Argentina Radioactive Tracer Market, by Tracer Types
10.1.2.2.4 Argentina Radioactive Tracer Market, by Test Type
10.1.2.2.5 Argentina Radioactive Tracer Market, by Application
10.1.2.2.6 Argentina Radioactive Tracer Market, by End-User
10.1.2.3 Rest of South & Central America
10.1.2.3.1 Overview
10.1.2.3.2 Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.3.3 Rest of South & Central America Radioactive Tracer Market, by Tracer Types
10.1.2.3.4 Rest of South & Central America Radioactive Tracer Market, by Test Type
10.1.2.3.5 Rest of South & Central America Radioactive Tracer Market, by Application
10.1.2.3.6 Rest of South & Central America Radioactive Tracer Market, by End-User
11. Radioactive Tracer Market Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Radioactive Tracer Market, Key Company Profiles
12.1 Rotem Industries Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Invicro LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Cardinal Health Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Newcastle University
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Novartis AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Curium
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 General Electric Co
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 IBA Radiopharma Solutions
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. South & Central America Radioactive Tracer Market Segmentation
Table 2. Principal Radionuclides Used in Radioactive Tracer
Table 3. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Tracer Types
Table 4. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Test Type
Table 5. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 6. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – End-User
Table 7. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Tracer Types
Table 8. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Test Type
Table 9. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 10. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – End-User
Table 11. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Tracer Types
Table 12. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Test Type
Table 13. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 14. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – End-User
Table 15. Organic Developments Done by Companies
Table 16. Inorganic Developments Done by Companies
Table 17. Glossary of Terms, South & Central America Radioactive Tracer Market
LIST OF FIGURES
Figure 1. South & Central America Radioactive Tracer Market Segmentation, By Country
Figure 2. South & Central America Radioactive Tracer Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Radioactive Tracer Market Revenue (US$ Mn), 2022 – 2030
Figure 5. South & Central America Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
Figure 6. Technetium 99m and TC-97m: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Iodine 131: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Iron 59: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Lutetium- 171: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. RB82 and ammonia N-13: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Scandium 46: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Seaborgium-269: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Hassium -269: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Gallium Citrate GA 67: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. PSMA GA68: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. FDDNP (F-18) and FDOPA (f-18): South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Phosphorus 32 and Chromium -51: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Thallium-201: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. F-18 FDG: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. F-18 FAPI: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. GA 68 FAPI: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. F-18 PSMA: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. DOTATOC/DOTANOC/DOTATATE Ga 68: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. South & Central America Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 26. PET: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. SPECT: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. South & Central America Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
Figure 30. Oncology: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pulmonary: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Neurology: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. Cardiology: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. Others: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. South & Central America Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
Figure 36. Hospitals and Clinics: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. Diagnostic Centers: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 38. Academic and Research Institutes: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 39. Others: South & Central America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 40. South & Central America Radioactive Tracer Market, By Geography, 2022 ($Mn)
Figure 41. South & Central America Radioactive Tracer Market, By Key Countries, 2022 and 2030 (%)
Figure 42. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 44. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
The List of Companies – South & Central America Radioactive Tracer Market
o Rotem Industries Ltd
o Invicro LLC
o Cardinal Health Inc
o Newcastle University
o Novartis AG
o Curium
o General Electric Co
o IBA Radiopharma Solutions
You must be logged in to post a review.
Reviews
There are no reviews yet.